The last 24 hours at the WPC have been pretty action packed. Before I summarise the new stuff here are some answers to the questions and comments.
GG - there isn't a session specifically devoted to DAs and OCB effects but the issues have been mentioned in lots of the other sessions. It is accepted that obsessive and compulsive behaviours can occur and that PwPs and their partners, caregivers & professionals all have to be watchful particularly where DAs are in use.
Poker - yes, Exenatide was mentioned. A couple of speakers have highlighted the recently published promising findings from the initial trials which were published earlier this year, and that follow up trials are in the pipeline. There's more on the exenatide story so far on the Parkinson's UK website just search for 'exenatide'
Semele - yes Selegeline & Rasagiline (the MAOB inhibitors) were mentioned as examples of drugs that have been tested for neuroprotective effects. The general consensus seems to be that while there have been some promising findings from trials of MAOB inhibitors, their neuroprotective effect is still debatable and any neuroprotection is likely to be very slight.
At the moment no treatments have been proven to slow the development of Parkinson's but there's plenty of hope that some of the treatments being developed and tested now could.
In the meantime, exercise seems like our best bet but there's no hard and fast rules about what kind works best. There are people here advocating and demonstrating many different regimes but the best advice seems to be find something you enjoy and do that.
Finally - Sheryll - Its great to know that we have a forum member in Portland, Oregon where WPC2016 will take place.